Catalyst Wire Dossier Catalyst Wire Dossier

CYT003

· Cytos Biotechnology AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CYT003, covering 2014-05-14 to 2014-05-14. Get the full timeline:

Most recent: Clinical Trial Update: CYT003 in Patients With Mild to Moderate Allergic Asthma Not Sufficiently Controlled on Inhaled Glucocorticosteroids [Phase 2]

See pricing